BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21489904)

  • 1. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
    de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
    Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
    Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
    Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
    Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
    Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
    Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
    Coors E
    Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Total cutaneous electron beam therapy of mycosis fungoides].
    Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
    Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
    Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
    Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.
    Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O
    J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
    Lokitz ML; Wong HK
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
    Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients.
    Ghodsi SZ; Hallaji Z; Balighi K; Safar F; Chams-Davatchi C
    Clin Exp Dermatol; 2005 Jul; 30(4):376-8. PubMed ID: 15953074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides.
    Nisticò S; Costanzo A; Saraceno R; Chimenti S
    Br J Dermatol; 2004 Oct; 151(4):877-9. PubMed ID: 15491430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term control of mycosis fungoides of the hands with topical bexarotene.
    Lain T; Talpur R; Duvic M
    Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
    Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.